Lubin Investment · Blog

Should you buy Interparfums (IPAR) stock?

2026-07-14 ·

IPAR: see the full analysis on Lubin Investment

Interparfums scores 9 out of 10 in my quality screen, powered by a business model that licenses fragrance brands rather than owning them. The business is solid, but the stock currently trades slightly above my reasonable buy price. Here is why quality alone is not enough to decide.

A perfume company that owns no brands

Interparfums does not create any of the brands you come across at an airport or a department store. The company develops, manufactures, and distributes fragrances under names it licenses from others: Coach, Montblanc, Guess, Jimmy Choo, Van Cleef & Arpels, Lacoste, Ferragamo, Donna Karan, and about twenty more. It is a licensing model, a bit like a movie studio that produces Marvel films without owning Marvel: Interparfums pays a royalty to the brand owner in exchange for the exclusive right to create and sell fragrances under that name, generally for a term fixed in advance, up to twenty years in the case of the Nautica agreement signed in January 2026.

This model has a direct consequence on the numbers: Interparfums barely needs factories or a giant portfolio of owned brands to maintain. My quality screen gives it 9 out of 10, driven precisely by this capital efficiency. But a good business model does not mean a cheap price, and that is exactly the nuance of this article.

A 9 out of 10 score, driven by capital returns

My screen runs every company through ten concrete criteria. Interparfums passes nine of them. Sales grow 15.6% per year on average, a solid pace for a company already well established in its sector. Its return on invested capital, what the company earns on every dollar actually deployed in the business, reaches 17.7%, a high figure that stems precisely from the licensing model: no need to tie up huge capital in perfume factories, the value comes from the brand and the distribution.

Earnings per share grew 78.4% per year over the recent period, an impressive pace reflecting the leverage of the model: every license contract that gains momentum (Coach grew 30% in the first quarter of 2026, Roberto Cavalli 32%) adds revenue on top of a cost structure that barely moves. The reverse is also true: Lacoste fell 12% over the same period, a brand pulling back after an exceptionally strong prior year comparison. That is the flip side of the licensing model, performance depends on a brand portfolio where some names are rising while others cool off.

The weak spot: cash that takes a while to come back

The one criterion that fails for Interparfums is the cash collection cycle: the company takes on average 274 days between recording a sale and actually collecting the corresponding cash, over nine months. That is long, and deserves an explanation rather than a raw, worrying number. Luxury perfume distribution runs through many intermediaries (wholesalers, duty free, department stores), to whom the company grants generous payment terms to stay competitive against other licensing houses, and it also has to hold significant inventory to supply dozens of markets simultaneously.

This is not an alarm bell in itself, as long as the company keeps a healthy balance sheet to fund this working capital need, which is the case here: net debt is only 0.42 times annual free cash flow. But it is something I watch over time, since a further lengthening of payment terms could signal a loss of negotiating power against distributors.

The price: a valuation that leaves little room left

To judge what the market is paying for Interparfums, I look at P/FCF (price to free cash flow), the share price divided by the cash actually generated each year. At its current price of around $118 as of mid-July 2026, Interparfums trades at about 19 times its free cash flow. That is not excessive for a company of this quality, but it is not a bargain either anymore.

Combining current profitability with conservative growth assumptions, my model puts Interparfums's reasonable buy price around $106.30. The stock therefore trades about 11% above that entry point. That is not a dramatic overvaluation, but it means that at this price, the stock no longer offers me a margin of safety: I would be paying for a good business, with no cushion in case of a bad surprise.

Quality and price: two separate questions

This is exactly the kind of situation where I refuse to mix up two different questions. Is it a good business? Clearly yes: a capital efficient model, a diversified brand portfolio, a healthy balance sheet, real growth. Is it the right price today? Not really, or at least not with the margin of safety I usually look for. A good business bought too dear can still disappoint in the stock market, even if the underlying business keeps performing well, simply because the market had already priced in all the good news.

Interparfums reports earnings on July 21, 2026. An acceleration in its fastest growing licenses (Coach, Montblanc) could justify paying a bit more; a slowdown would bring the price closer to my entry point. Either way, I would rather wait for the price to come to me than pay a premium for a story the market already knows well.

How I am calling it

Interparfums is a quality business, with an operating model I particularly like for its capital efficiency. But quality alone is never enough: at the current price, the stock no longer offers the margin of safety I look for. I would rather keep watching this one and wait for a more favorable entry point than pay today for a story the market already knows well.

FAQ

What is a licensing model in the perfume industry?

A company like Interparfums does not own the brands whose fragrances it sells. It pays a royalty to the brand owner (Coach, Montblanc, Nautica) in exchange for the exclusive right to create, manufacture, and distribute fragrances under that name, generally for a term fixed in advance.

Why is Interparfums's cash collection cycle so long?

Luxury perfume distribution runs through many intermediaries (wholesalers, duty free, department stores) to whom the company grants generous payment terms, and it has to hold inventory to supply dozens of markets at once. This is not alarming as long as the balance sheet stays healthy.

What is P/FCF (price to free cash flow)?

The share price divided by free cash flow, the cash a company genuinely generates each year. A P/FCF of 19 means you are paying nineteen years of that cash to own the company today.

Should you buy Interparfums stock now?

My model puts the reasonable buy price around $106.30 against a share price around $118 in mid-July 2026, which leaves no margin of safety at the current price. This is not personalized investment advice, do your own research.

What is the main risk on this name?

The brand portfolio depends on time-limited licensing contracts: losing an important brand at renewal, or a slowdown in the brands currently driving growth (Coach, Montblanc), would directly hit results.

IPAR: see the full analysis on Lubin Investment

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).